{
    "clinical_study": {
        "@rank": "70356", 
        "arm_group": [
            {
                "arm_group_label": "XAF5", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "This is a study to assess the safety, tolerability, and pharmacokinetics of XAF5 Gel when\n      applied to the skin of healthy volunteers."
        }, 
        "brief_title": "Safety Study of XAF5 Gel Applied to Skin of Healthy Volunteers", 
        "completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "condition": "Healthy", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy volunteers\n\n          -  Must understand and provide informed consent\n\n          -  Skin upon which a reaction would be visible\n\n          -  Body weight >= 70 kg\n\n        Exclusion Criteria:\n\n          -  Any active skin disease\n\n          -  History of skin hypersensitivity\n\n          -  Clinically significant abnormality on physical exam, ECG, or laboratory tests\n\n          -  Positive test for HIV, Hepatitis B, or Hepatitis C"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "60 Years", 
            "minimum_age": "25 Years"
        }, 
        "enrollment": {
            "#text": "32", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 5, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01723241", 
            "org_study_id": "XAF5 A1"
        }, 
        "intervention": [
            {
                "arm_group_label": "XAF5", 
                "intervention_name": "XAF5, concentration A", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "XAF5", 
                "intervention_name": "XAF5, concentration B", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "XAF5", 
                "intervention_name": "XAF5, concentration C", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": "volunteers", 
        "lastchanged_date": "April 19, 2013", 
        "number_of_arms": "2", 
        "official_title": "A Randomized, Placebo-controlled, Double-blind, Multiple-ascending-dose Study to Assess the Safety and Tolerability of XAF5 Gel Applied to the Skin of Healthy Volunteers", 
        "overall_official": {
            "affiliation": "Topokine Therapeutics", 
            "last_name": "Michael S. Singer, MD, PhD", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01723241"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Topokine Therapeutics, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Topokine Therapeutics, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}